IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tyndall Capital Partners L P

Q3 2017 Holdings

Filed 2017-11-14 | 4 holdings | $7.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pendrell CorpCL A NEW70686R302$4.3K625,93554.6%
Onconova Therapeutics IncCOM NEW68232V306$1.7K997,02221.8%
MMA Cap Mgmt LLC(MMAC)COM55315D105$1.7K67,55221.6%
Onconova Therapeutics Inc*W EXP 07/07/20268232V116$152390,6241.9%